Atrial fibrillation (AF) management is undergoing a transformative shift, embracing an early, comprehensive approach that integrates risk factor control and intervention. Traditional anti-arrhythmic medications are being enhanced by innovative agents, while catheter ablation has advanced with Pulsed Field ...
One way to control your AFib is to take rhythm control medication, which helps your heart return to and stay in a normal rhythm. This is also known as drugcardioversionor chemical cardioversion. Rhythm control drugs carry risks and require that your heart be monitored closely. It may also tak...
Rate Control in Atrial Fibrillation: Choice of Treatment and Assessment of Efficacy The clinical relevance and high social costs of atrial fibrillation have boosted interest in rate control as a cost-effective alternative to long-term main... G Boriani,M Biffi,I Diemberger,... - 《Drugs》 被...
The value of antiarrhythmics to maintain normal sinus rhythm in patients with atrial fibrillation (AF) and heart failure (HF) is still being debated. We aimed to determine whether rhythm control using antiarrhythmic drugs (AADs) is more effective than rate control in improving outcomes in this ...
Long-term rhythm control of drug-refractory atrial fibrillation with “hybrid therapy” incorporating dual-site right atrial pacing, antiarrhythmic drugs, ... We evaluated the long-term efficacy, safety, and applicability of a “hybrid” therapy strategy for rhythm control in atrial fibrillation (AF...
Although amiodarone is the most effective rhythm control agent, its adverse effect profile suggests it should be reserved for use when other antiarrhythmic drugs fail or are contraindicated. To date, “upstream” or preventive therapies have not been specifically evaluated in the elderly but nebivolol...
Pharmacologic Rate versus Rhythm‐Control Strategies in Atrial Fibrillation: An Updated Comprehensive Review and Meta‐Analysis Background: In patients with atrial fibrillation (AF), ventricular rate control with medications has been found to be noninferior in preventing clinical ev... S Chatterjee,P ...
Therefore, the therapeutic aim should be rhythm control or rate control. The results of large trials, e.g., AFFIRM study, suggested that rate control is as good as rhythm control. Considering the limitations of these studies and the development of new antiarrhythmic drugs and interventional ...
UK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, which could be used as a treatment for atrial fibrillation without the need for medication.
BACKGROUND: Patients with atrial fibrillation (AF) can be managed either by maintaining sinus rhythm using antiarrhythmic drugs and/or electrical cardioversion, or by leaving patients in AF and controlling ventricular rate without attempts to restore sinus rhythm. Which of these two strategies is super...